THE IMPACT OF GLP-1 INDUCED NAUSEA AND VOMITING ON WORK PRODUCTIVITY AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH T2DM
OBJECTIVES: To assess the impact of GLP-1-induced nausea and vomiting on patients with T2DM using the 'Nausea and Vomiting Questionnaire' (NVQ) and additional questionnaires designed to gather information on health-related quality of life (HRQOL) and work productivity. METHODS: A non-inter...
Gespeichert in:
Veröffentlicht in: | Value in health 2017-05, Vol.20 (5), p.A172 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 5 |
container_start_page | A172 |
container_title | Value in health |
container_volume | 20 |
creator | McLeod, L Sikirica, MV Davenport, E Sweeney, CT Joshi, AV |
description | OBJECTIVES: To assess the impact of GLP-1-induced nausea and vomiting on patients with T2DM using the 'Nausea and Vomiting Questionnaire' (NVQ) and additional questionnaires designed to gather information on health-related quality of life (HRQOL) and work productivity. METHODS: A non-interventional, cross-sectional survey, was administered to T2DM patients. Screened respondents provided demographics, self-reported clinical and treatment information, and nausea- and/or vomiting-related resource utilization. Inclusion required T2DM diagnosis, age 18+ years and GLP-1 agonist treatment (among other criteria). Question S14 ("In the past 7 days, have you had any nausea or vomiting after using your GLP-1 medicine?") designated eligibility for the impact survey. Enrolled participants also completed four patient-reported outcome (PRO) measures, including: NVQ Functional Living Index-Emesis (FLIE), Work Productivity and Activity Impairment: Specific Health Problem (WPAI:SHP), and the MOS SF-12. Descriptive statistics were tabulated for all screener (eligible and ineligible responders) and survey questions (eligible only). RESULTS: Overall, 1,026 respondents completed screening, including 204 enrollees reporting nausea and/or vomiting in the past 7 days. Eligible patients were 66% male, white (84%), non-Hispanic (75%), average (SD) age 41(11) years, with a diagnosis of T2DM between 3 and 9 years ago (53%) and 90% were first time GLP-1 users. Respondents (>60%) reported that nausea and/or vomiting (at its worst) impacted their relationships, work productivity, eating, sleeping, and amount of energy spent during the past 7 days. Respondents indicated using prescription (32%) and over-the-counter medications (26%) to treat nausea/vomiting. The questionnaire scores were: NVQ mean (SD) score = 52.3 (22.5), WPAI absenteeism/presenteeism/producnvity loss = 22.8 (25.2) / 56.0 (27.6) / 62.2 (29.9), and SF-12 Mental / Physical = 42.7 (8.3)/ 44.6 (7.2) for the overall group. CONCLUSIONS: This survey study shows that although there was a significant impact of nausea and vomiting on work productivity, the impact on HRQoL was relatively modest. |
doi_str_mv | 10.1016/j.jval.2017.05.005 |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2097665922</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2097665922</sourcerecordid><originalsourceid>FETCH-proquest_journals_20976659223</originalsourceid><addsrcrecordid>eNqNjTFPwzAUhC0EEqXwB5iexJzwbNcJGa3EaawmdkhfWjFVHcoQVRQaysZ_r0H8AKY76b67Y-yeY8yRJ49DPHxt97FAnsaoYkR1wSZciVk0S6W8DB6zp0giV9fsZhwHREykUBP2TZUB27Q6J_AlzOs24mBd0eemAKf7pdGgXQEr31iybg7ewdp3C2g7HyCyK0svv0RldE1V1JlaU-g-97r-icJobcvw4aDVZI2jJawtVUCiaG7Z1et2P-7u_nTKHkpDeRW9Hw8fp934uRkOp-NbiDYCszRJVCaE_B91Bvg1Shg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2097665922</pqid></control><display><type>article</type><title>THE IMPACT OF GLP-1 INDUCED NAUSEA AND VOMITING ON WORK PRODUCTIVITY AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH T2DM</title><source>Elsevier ScienceDirect Journals Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><creator>McLeod, L ; Sikirica, MV ; Davenport, E ; Sweeney, CT ; Joshi, AV</creator><creatorcontrib>McLeod, L ; Sikirica, MV ; Davenport, E ; Sweeney, CT ; Joshi, AV</creatorcontrib><description>OBJECTIVES: To assess the impact of GLP-1-induced nausea and vomiting on patients with T2DM using the 'Nausea and Vomiting Questionnaire' (NVQ) and additional questionnaires designed to gather information on health-related quality of life (HRQOL) and work productivity. METHODS: A non-interventional, cross-sectional survey, was administered to T2DM patients. Screened respondents provided demographics, self-reported clinical and treatment information, and nausea- and/or vomiting-related resource utilization. Inclusion required T2DM diagnosis, age 18+ years and GLP-1 agonist treatment (among other criteria). Question S14 ("In the past 7 days, have you had any nausea or vomiting after using your GLP-1 medicine?") designated eligibility for the impact survey. Enrolled participants also completed four patient-reported outcome (PRO) measures, including: NVQ Functional Living Index-Emesis (FLIE), Work Productivity and Activity Impairment: Specific Health Problem (WPAI:SHP), and the MOS SF-12. Descriptive statistics were tabulated for all screener (eligible and ineligible responders) and survey questions (eligible only). RESULTS: Overall, 1,026 respondents completed screening, including 204 enrollees reporting nausea and/or vomiting in the past 7 days. Eligible patients were 66% male, white (84%), non-Hispanic (75%), average (SD) age 41(11) years, with a diagnosis of T2DM between 3 and 9 years ago (53%) and 90% were first time GLP-1 users. Respondents (>60%) reported that nausea and/or vomiting (at its worst) impacted their relationships, work productivity, eating, sleeping, and amount of energy spent during the past 7 days. Respondents indicated using prescription (32%) and over-the-counter medications (26%) to treat nausea/vomiting. The questionnaire scores were: NVQ mean (SD) score = 52.3 (22.5), WPAI absenteeism/presenteeism/producnvity loss = 22.8 (25.2) / 56.0 (27.6) / 62.2 (29.9), and SF-12 Mental / Physical = 42.7 (8.3)/ 44.6 (7.2) for the overall group. CONCLUSIONS: This survey study shows that although there was a significant impact of nausea and vomiting on work productivity, the impact on HRQoL was relatively modest.</description><identifier>ISSN: 1098-3015</identifier><identifier>EISSN: 1524-4733</identifier><identifier>DOI: 10.1016/j.jval.2017.05.005</identifier><language>eng</language><publisher>Lawrenceville: Elsevier Science Ltd</publisher><subject>Absenteeism ; Averages ; Demography ; Diabetes ; Diagnosis ; GLP-1 receptor agonists ; Health problems ; Health status ; Medical diagnosis ; Medical screening ; National Vocational Qualifications ; Nausea ; Patients ; Polls & surveys ; Productivity ; Quality of life ; Questionnaires ; Resource utilization ; Vomiting ; Work</subject><ispartof>Value in health, 2017-05, Vol.20 (5), p.A172</ispartof><rights>Copyright Elsevier Science Ltd. May 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,30999</link.rule.ids></links><search><creatorcontrib>McLeod, L</creatorcontrib><creatorcontrib>Sikirica, MV</creatorcontrib><creatorcontrib>Davenport, E</creatorcontrib><creatorcontrib>Sweeney, CT</creatorcontrib><creatorcontrib>Joshi, AV</creatorcontrib><title>THE IMPACT OF GLP-1 INDUCED NAUSEA AND VOMITING ON WORK PRODUCTIVITY AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH T2DM</title><title>Value in health</title><description>OBJECTIVES: To assess the impact of GLP-1-induced nausea and vomiting on patients with T2DM using the 'Nausea and Vomiting Questionnaire' (NVQ) and additional questionnaires designed to gather information on health-related quality of life (HRQOL) and work productivity. METHODS: A non-interventional, cross-sectional survey, was administered to T2DM patients. Screened respondents provided demographics, self-reported clinical and treatment information, and nausea- and/or vomiting-related resource utilization. Inclusion required T2DM diagnosis, age 18+ years and GLP-1 agonist treatment (among other criteria). Question S14 ("In the past 7 days, have you had any nausea or vomiting after using your GLP-1 medicine?") designated eligibility for the impact survey. Enrolled participants also completed four patient-reported outcome (PRO) measures, including: NVQ Functional Living Index-Emesis (FLIE), Work Productivity and Activity Impairment: Specific Health Problem (WPAI:SHP), and the MOS SF-12. Descriptive statistics were tabulated for all screener (eligible and ineligible responders) and survey questions (eligible only). RESULTS: Overall, 1,026 respondents completed screening, including 204 enrollees reporting nausea and/or vomiting in the past 7 days. Eligible patients were 66% male, white (84%), non-Hispanic (75%), average (SD) age 41(11) years, with a diagnosis of T2DM between 3 and 9 years ago (53%) and 90% were first time GLP-1 users. Respondents (>60%) reported that nausea and/or vomiting (at its worst) impacted their relationships, work productivity, eating, sleeping, and amount of energy spent during the past 7 days. Respondents indicated using prescription (32%) and over-the-counter medications (26%) to treat nausea/vomiting. The questionnaire scores were: NVQ mean (SD) score = 52.3 (22.5), WPAI absenteeism/presenteeism/producnvity loss = 22.8 (25.2) / 56.0 (27.6) / 62.2 (29.9), and SF-12 Mental / Physical = 42.7 (8.3)/ 44.6 (7.2) for the overall group. CONCLUSIONS: This survey study shows that although there was a significant impact of nausea and vomiting on work productivity, the impact on HRQoL was relatively modest.</description><subject>Absenteeism</subject><subject>Averages</subject><subject>Demography</subject><subject>Diabetes</subject><subject>Diagnosis</subject><subject>GLP-1 receptor agonists</subject><subject>Health problems</subject><subject>Health status</subject><subject>Medical diagnosis</subject><subject>Medical screening</subject><subject>National Vocational Qualifications</subject><subject>Nausea</subject><subject>Patients</subject><subject>Polls & surveys</subject><subject>Productivity</subject><subject>Quality of life</subject><subject>Questionnaires</subject><subject>Resource utilization</subject><subject>Vomiting</subject><subject>Work</subject><issn>1098-3015</issn><issn>1524-4733</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><recordid>eNqNjTFPwzAUhC0EEqXwB5iexJzwbNcJGa3EaawmdkhfWjFVHcoQVRQaysZ_r0H8AKY76b67Y-yeY8yRJ49DPHxt97FAnsaoYkR1wSZciVk0S6W8DB6zp0giV9fsZhwHREykUBP2TZUB27Q6J_AlzOs24mBd0eemAKf7pdGgXQEr31iybg7ewdp3C2g7HyCyK0svv0RldE1V1JlaU-g-97r-icJobcvw4aDVZI2jJawtVUCiaG7Z1et2P-7u_nTKHkpDeRW9Hw8fp934uRkOp-NbiDYCszRJVCaE_B91Bvg1Shg</recordid><startdate>20170501</startdate><enddate>20170501</enddate><creator>McLeod, L</creator><creator>Sikirica, MV</creator><creator>Davenport, E</creator><creator>Sweeney, CT</creator><creator>Joshi, AV</creator><general>Elsevier Science Ltd</general><scope>7QJ</scope></search><sort><creationdate>20170501</creationdate><title>THE IMPACT OF GLP-1 INDUCED NAUSEA AND VOMITING ON WORK PRODUCTIVITY AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH T2DM</title><author>McLeod, L ; Sikirica, MV ; Davenport, E ; Sweeney, CT ; Joshi, AV</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_20976659223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Absenteeism</topic><topic>Averages</topic><topic>Demography</topic><topic>Diabetes</topic><topic>Diagnosis</topic><topic>GLP-1 receptor agonists</topic><topic>Health problems</topic><topic>Health status</topic><topic>Medical diagnosis</topic><topic>Medical screening</topic><topic>National Vocational Qualifications</topic><topic>Nausea</topic><topic>Patients</topic><topic>Polls & surveys</topic><topic>Productivity</topic><topic>Quality of life</topic><topic>Questionnaires</topic><topic>Resource utilization</topic><topic>Vomiting</topic><topic>Work</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McLeod, L</creatorcontrib><creatorcontrib>Sikirica, MV</creatorcontrib><creatorcontrib>Davenport, E</creatorcontrib><creatorcontrib>Sweeney, CT</creatorcontrib><creatorcontrib>Joshi, AV</creatorcontrib><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><jtitle>Value in health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McLeod, L</au><au>Sikirica, MV</au><au>Davenport, E</au><au>Sweeney, CT</au><au>Joshi, AV</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>THE IMPACT OF GLP-1 INDUCED NAUSEA AND VOMITING ON WORK PRODUCTIVITY AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH T2DM</atitle><jtitle>Value in health</jtitle><date>2017-05-01</date><risdate>2017</risdate><volume>20</volume><issue>5</issue><spage>A172</spage><pages>A172-</pages><issn>1098-3015</issn><eissn>1524-4733</eissn><abstract>OBJECTIVES: To assess the impact of GLP-1-induced nausea and vomiting on patients with T2DM using the 'Nausea and Vomiting Questionnaire' (NVQ) and additional questionnaires designed to gather information on health-related quality of life (HRQOL) and work productivity. METHODS: A non-interventional, cross-sectional survey, was administered to T2DM patients. Screened respondents provided demographics, self-reported clinical and treatment information, and nausea- and/or vomiting-related resource utilization. Inclusion required T2DM diagnosis, age 18+ years and GLP-1 agonist treatment (among other criteria). Question S14 ("In the past 7 days, have you had any nausea or vomiting after using your GLP-1 medicine?") designated eligibility for the impact survey. Enrolled participants also completed four patient-reported outcome (PRO) measures, including: NVQ Functional Living Index-Emesis (FLIE), Work Productivity and Activity Impairment: Specific Health Problem (WPAI:SHP), and the MOS SF-12. Descriptive statistics were tabulated for all screener (eligible and ineligible responders) and survey questions (eligible only). RESULTS: Overall, 1,026 respondents completed screening, including 204 enrollees reporting nausea and/or vomiting in the past 7 days. Eligible patients were 66% male, white (84%), non-Hispanic (75%), average (SD) age 41(11) years, with a diagnosis of T2DM between 3 and 9 years ago (53%) and 90% were first time GLP-1 users. Respondents (>60%) reported that nausea and/or vomiting (at its worst) impacted their relationships, work productivity, eating, sleeping, and amount of energy spent during the past 7 days. Respondents indicated using prescription (32%) and over-the-counter medications (26%) to treat nausea/vomiting. The questionnaire scores were: NVQ mean (SD) score = 52.3 (22.5), WPAI absenteeism/presenteeism/producnvity loss = 22.8 (25.2) / 56.0 (27.6) / 62.2 (29.9), and SF-12 Mental / Physical = 42.7 (8.3)/ 44.6 (7.2) for the overall group. CONCLUSIONS: This survey study shows that although there was a significant impact of nausea and vomiting on work productivity, the impact on HRQoL was relatively modest.</abstract><cop>Lawrenceville</cop><pub>Elsevier Science Ltd</pub><doi>10.1016/j.jval.2017.05.005</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1098-3015 |
ispartof | Value in health, 2017-05, Vol.20 (5), p.A172 |
issn | 1098-3015 1524-4733 |
language | eng |
recordid | cdi_proquest_journals_2097665922 |
source | Elsevier ScienceDirect Journals Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Applied Social Sciences Index & Abstracts (ASSIA) |
subjects | Absenteeism Averages Demography Diabetes Diagnosis GLP-1 receptor agonists Health problems Health status Medical diagnosis Medical screening National Vocational Qualifications Nausea Patients Polls & surveys Productivity Quality of life Questionnaires Resource utilization Vomiting Work |
title | THE IMPACT OF GLP-1 INDUCED NAUSEA AND VOMITING ON WORK PRODUCTIVITY AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH T2DM |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T05%3A36%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=THE%20IMPACT%20OF%20GLP-1%20INDUCED%20NAUSEA%20AND%20VOMITING%20ON%20WORK%20PRODUCTIVITY%20AND%20HEALTH-RELATED%20QUALITY%20OF%20LIFE%20IN%20PATIENTS%20WITH%20T2DM&rft.jtitle=Value%20in%20health&rft.au=McLeod,%20L&rft.date=2017-05-01&rft.volume=20&rft.issue=5&rft.spage=A172&rft.pages=A172-&rft.issn=1098-3015&rft.eissn=1524-4733&rft_id=info:doi/10.1016/j.jval.2017.05.005&rft_dat=%3Cproquest%3E2097665922%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2097665922&rft_id=info:pmid/&rfr_iscdi=true |